Cedilanid-d en es it fr

Cedilanid-d Brand names, Cedilanid-d Analogs

Cedilanid-d Brand Names Mixture

  • No information avaliable

Cedilanid-d Chemical_Formula


Cedilanid-d RX_link

No information avaliable

Cedilanid-d fda sheet

Cedilanid-d msds (material safety sheet)

Cedilanid-d MSDS

Cedilanid-d Synthesis Reference

No information avaliable

Cedilanid-d Molecular Weight

469.964 g/mol

Cedilanid-d Melting Point

204.5 oC

Cedilanid-d H2O Solubility

3000 mg/L

Cedilanid-d State


Cedilanid-d LogP


Cedilanid-d Dosage Forms

Capsule (sustained-release); Liquid; Solution; Suppository; Syrup; Tablet; Tablet (extended-release)

Cedilanid-d Indication

Used for treating vertigo, motion sickness, and nausea associated with pregnancy.

Cedilanid-d Pharmacology

Dimenhydrinate is an antiemetics drug combination that contains diphenhydramine and theophylline. It is not effective in the treatment of nausea associated with cancer chemotherapy. Dimenhydrinate directly inhibits the stimulation of certain nerves in the brain and inner ear to suppress nausea, vomiting, dizziness, and vertigo.

Cedilanid-d Absorption

Well absorbed after oral administration.

Cedilanid-d side effects and Toxicity

Symptoms of overdose include delerium and hallucinations.

Cedilanid-d Patient Information

No information avaliable

Cedilanid-d Organisms Affected

Humans and other mammals